澳大利亚约40%的全科医生现已在患者咨询中使用AI抄写员工具进行记录转录，这一比例相比2024年8月的22%大幅增长[1]。这些工具能够自动转录对话、生成诊疗笔记并生成总结，但其可靠性存在重大隐患——2025年研究发现，AI抄写员生成的笔记中高达20%包含重大错误，其中遗漏是最常见的问题类型，约占所有错误的四分之三[1]。
医学界对这一技术的益处与风险看法不一。墨尔本大学的Andrew Cullen认为，患者从AI抄写员获得的益处不如医生明显，最主要的关切是AI错误可能导致误诊或不当治疗[1]。与此相反，澳大利亚皇家全科医学院的Janice Tan指出，这些工具通过减少医生下班后的文书工作量来缓解职业倦怠[1]。目前，AI抄写员由隐私法案和澳大利亚卫生从业者管制局指导覆盖，但治疗用品管理局仅在工具跨越医疗设备范畴时才进行监管[1]。
Approximately 40 percent of Australian general practitioners now use AI scribe tools to record patient consultations, marking a sharp rise from 22 percent in August 2024 [1]. These tools can transcribe conversations, generate automated clinical notes, and produce summaries of patient interactions [1].
However, the rapid adoption has raised serious concerns about patient safety and data protection. Research conducted in 2025 found that as many as 20 percent of notes generated by AI scribes contained significant errors [1]. The most common type of mistake was the omission of information, accounting for approximately three-quarters of all errors identified [1]. According to Andrew Cullen from the University of Melbourne, the benefits to patients are less clear than those experienced by doctors, with a primary concern being that AI errors could lead to misdiagnosis or inappropriate treatment [1].
Current regulatory oversight of AI scribes is fragmented. The tools are governed by the Privacy Act and the Australian Health Practitioner Regulation Agency, though the Therapeutic Goods Administration only becomes involved if a tool crosses into the medical device category [1]. Janice Tan from the Royal Australian College of General Practitioners has noted that the tools do reduce paperwork for doctors after hours, helping to alleviate professional burnout [1].